Clinical Trial Update: Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating dose tolerance, pharmacokinetics, and iodine uptake for recombinant human thyroid-stimulating hormone (rhTSH) in patients po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• rhTSH (recombinant human thyroid-stimulating hormone)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Differentiated Thyroid Cancer | Phase 1, Phase 2 | Status: COMPLETED